InsidersTradesSigma
Track the 红日药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 红日药业 has logged 17 insider filings. Market capitalisation: €10.2bn. The latest transaction was reported on 23 May 2023 (Sale). Among the most active insiders: 姚小青. The full history is openly available.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€28m
17 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,784 of 29,063 companies
42.5
score / 100
Value40
Quality45
FCF yld6.5%
Earn yld0.2%
EV/EBITDA24.7x
ROE0.3%
Gross mgn53%
Net mgn0.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 May 2023
Declarations17 total
17 of 17 declarations
About 红日药业
红日药业 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of medicines and pharmaceutical products.